Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 WOCKHARDT   MYLAN
EQUITY SHARE DATA
    WOCKHARDT
Mar-23
MYLAN
Dec-18
WOCKHARDT/
MYLAN
5-Yr Chart
Click to enlarge
High Rs3163,969-   
Low Rs1452,185-   
Sales per share (Unadj.) Rs184.01,826.3-  
Earnings per share (Unadj.) Rs-43.149.6-  
Cash flow per share (Unadj.) Rs-25.7391.5-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs231.71,975.7-  
Shares outstanding (eoy) m144.09514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.31.7 74.3%   
Avg P/E ratio x-5.362.0 -8.6%  
P/CF ratio (eoy) x-9.07.9 -114.2%  
Price / Book Value ratio x1.01.6 63.9%  
Dividend payout %00-   
Avg Mkt Cap Rs m33,2021,582,973 2.1%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m6,3700-   
Avg. sales/employee Rs Th026,846.0-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0729.0-  
INCOME DATA
Net Sales Rs m26,510939,609 2.8%  
Other income Rs m1,2200-   
Total revenues Rs m27,730939,609 3.0%   
Gross profit Rs m-1,930243,136 -0.8%  
Depreciation Rs m2,510175,932 1.4%   
Interest Rs m3,02045,192 6.7%   
Profit before tax Rs m-6,24022,012 -28.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-30-3,502 0.9%   
Profit after tax Rs m-6,21025,514 -24.3%  
Gross profit margin %-7.325.9 -28.1%  
Effective tax rate %0.5-15.9 -3.0%   
Net profit margin %-23.42.7 -862.7%  
BALANCE SHEET DATA
Current assets Rs m19,140524,677 3.6%   
Current liabilities Rs m34,350382,547 9.0%   
Net working cap to sales %-57.415.1 -379.3%  
Current ratio x0.61.4 40.6%  
Inventory Days Days3984 47.1%  
Debtors Days Days1193 11.8%  
Net fixed assets Rs m48,670182,269 26.7%   
Share capital Rs m720500 143.9%   
"Free" reserves Rs m32,6600-   
Net worth Rs m33,3801,016,486 3.3%   
Long term debt Rs m2,2401,097,114 0.2%   
Total assets Rs m70,7502,726,609 2.6%  
Interest coverage x-1.11.5 -71.7%   
Debt to equity ratio x0.11.1 6.2%  
Sales to assets ratio x0.40.3 108.7%   
Return on assets %-4.52.6 -173.9%  
Return on equity %-18.62.5 -741.2%  
Return on capital %-9.03.2 -284.3%  
Exports to sales %00-   
Imports to sales %3.50-   
Net fx Rs m-1900-   
CASH FLOW
From Operations Rs m1,530195,251 0.8%  
From Investments Rs m-1,250-100,923 1.2%  
From Financial Activity Rs m-3,150-90,959 3.5%  
Net Cashflow Rs m-2,8001,618 -173.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.38 Rs / USD

Compare WOCKHARDT With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare WOCKHARDT With: KIMIA BIOSCIENCES  EARUM PHARMACEUTICALS  AVON ORGANIC  HIKAL.  NECTAR LIFESCIENCE  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.